Home » Venture Capital » Current Portfolio

Current Portfolio

Flagship invests in three principle business sectors: Therapeutics; Health Technologies; and Sustainability/Clean Technology. Initial investments range between $250 thousand and $5 million, and we may invest up to $12-15 million during the life of a company. Click on a tab below to filter the listing of the portfolio by industry sector, or on a column heading to sort.

Company Descriptionsort icon Status Initial Date
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Private 2007 View Profile
<a href="/venture-capital/all-companies/blend-therapeutics-inc">Blend Therapeutics Inc.</a> Discovering new classes of medicines that have unique modes of action to result in drugs with differentiated therapeutic properties. Private 2012 View Profile
<a href="/venture-capital/all-companies/acceleron-pharma-inc">Acceleron Pharma, Inc.</a> Discovering, developing, manufacturing and commercializing novel protein therapeutics for orphan diseases and cancer. Private 2004 View Profile
<a href="/venture-capital/all-companies/t2-biosystems-inc">T2 Biosystems, Inc.</a> Disrupting the landscape of clinical diagnostics with T2MR. Private 2006 View Profile
<a href="/venture-capital/all-companies/transmedics-inc">TransMedics, Inc.</a> Extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure. Private 2010 View Profile
<a href="/venture-capital/all-companies/helicos-biosciences-corporation">Helicos BioSciences Corporation</a> Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. Public 2003 View Profile
<a href="/venture-capital/all-companies/oasys-water-inc">Oasys Water, Inc.</a> Leading the world in the development of forward osmosis based solutions for the treatment and desalination of high saline source waters. Private 2009 View Profile
<a href="/venture-capital/all-companies/syros-pharmaceuticals-0">Syros Pharmaceuticals</a> Life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Private 2012 View Profile
<a href="/venture-capital/all-companies/bg-medicine-inc">BG Medicine, Inc.</a> Novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. Public 2000 View Profile
<a href="/venture-capital/all-companies/black-duck-software-inc">Black Duck Software, Inc.</a> Offering award-winning software and consulting. Private 2004 View Profile
<a href="/venture-capital/all-companies/permeon-biologics-inc">Permeon Biologics Inc.</a> Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Private 2011 View Profile
<a href="/venture-capital/all-companies/seres-health">Seres Health</a> Pioneering a new class of therapeutics that, for the first time, catalyzes health in multiple important therapeutic areas. Private 2012 View Profile
<a href="/venture-capital/all-companies/aerodesigns-inc">AeroDesigns Inc.</a> Pioneering air-based delivery systems to reimagine the consumption of food, nutrients and medications. Private 2011 View Profile
<a href="/venture-capital/all-companies/moderna">moderna</a> Pioneering an entirely new drug modality using messenger RNA therapeutics™. Private 2010 View Profile
<a href="/venture-capital/all-companies/selventa">Selventa</a> Pioneering the development of Systems Diagnostics (SysDx(TM)). Private 2001 View Profile
<a href="/venture-capital/all-companies/seahorse-bioscience-inc">Seahorse Bioscience, Inc.</a> Providing XFe Analyzers and stress test kits that are becoming the industry standard in cell metabolism measurements. Private 2001 View Profile
<a href="/venture-capital/all-companies/affinnova-inc">Affinnova, Inc.</a> Software and services used by brands to dramatically improve their innovation and marketing success rate. Private 2000 View Profile
<a href="/venture-capital/all-companies/ls9-inc">LS9, Inc.</a> Technology leader in the commercial development of a growing portfolio of sustainable products to meet the needs of chemical and fuel markets worldwide. Private 2005 View Profile
<a href="/venture-capital/all-companies/pronutria">Pronutria</a> Transforming global nutrition. Private 2010 View Profile